drug response phenotype

Aliases

inter‑individual differences in drug response

Related entities (1)

Mentioned in (17)

Papers in which this entity is mentioned.

• Flexynesis: A deep learning toolkit for bulk multi-omics data integration for precision oncology and beyond. (2025)
• Genome-wide association testing beyond SNPs. (2025)
• Synthetic augmentation of cancer cell line multi-omic datasets using unsupervised deep learning. (2024)
• The landscape of drug sensitivity and resistance in sarcoma. (2024)
• Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology. (2024)
• The Application of Long-Read Sequencing to Cancer. (2024)
• RNA splicing dysregulation and the hallmarks of cancer. (2023)
• Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer. (2018)
• Patient-derived xenografts undergo mouse-specific tumor evolution. (2017)
• Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. (2017)
• Development and clinical application of an integrative genomic approach to personalized cancer therapy. (2016)
• A gene-based association method for mapping traits using reference transcriptome data. (2015)
• HLAreporter: a tool for HLA typing from next generation sequencing data. (2015)
• DNA methylation contributes to natural human variation. (2013)
• Combined analysis of circulating β-endorphin with gene polymorphisms in OPRM1, CACNAD2 and ABCB1 reveals correlation with pain, opioid sensitivity and opioid-related side effects. (2013)
• Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate. (2013)
• Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective. (2012)

Merged raw entities (2)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.